Elemene, one ingredient of a chinese herb, against malignant tumors: A literature-based meta-analysis

Cancer Investigation

Volumn 31, Issue 2, 2013, Pages 156-166

  Xu, Hong Bin ^a   Zheng, Long Po ^a   Li, Ling ^a   Xu, Lu Zhong ^a   Fu, Jun ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Elemene; Malignant tumors; Meta analysis

Indexed keywords

BETA ELEMENE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; FOLINATE CALCIUM; GEMCITABINE; MITOMYCIN; NAVELBINE; PACLITAXEL; PIRARUBICIN; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CHINESE HERB; COCHRANE LIBRARY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; EMBASE; HUMAN; LEUKOPENIA; LIVER CELL CARCINOMA; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MEDICAL LITERATURE; META ANALYSIS; PRIORITY JOURNAL; REVIEW; STOMACH CARCINOMA; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUGS, CHINESE HERBAL; HUMANS; NEOPLASMS; SESQUITERPENES;

EID: 84873136008     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2012.756108     Document Type: Review

References (57)

1. Jemal A, Bray F, Center MM, Ferlay J,Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Guo YT. Isolation and identification of elemene fromthe essential oil of Curcuma wenyujin. Zhong Yao Tong Bao 1983;8:31.
3. Tang XH, Qin SK, Xie T. Status and progress of basic researches of elemene injection for anti-tumor. Chin J Clin Oncol 2010;15:266-273.
4. Zhao YL, Peng XX,Wang YD. Elemene injections for pulmonary cancer: a systematic review. Chin J EBM 2005;5:216-223.
5. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12. (Pubitemid 26120810)
6. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188. (Pubitemid 17189972)
7. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560. (Pubitemid 37088507)
8. Lu LQ, Liu ZJ, Chen FH. Effect of elemene emulsion against lung cancer by intervention therapy. Zhejiang J Oncol 1996;2:185.
9. Li X, Xu SX, Shang GY. Comparison of elemene and general medicine against lung cancer by double artery injection. Zhong Liu Fang Zhi Yan Jiu 1996;23:369-371.
10. Qin SK, Qian J,Wang L. The clinical study on the plan of elemene emulsion with CTV to treat lung cancer. Zhong Liu Fang Zhi Yan Jiu 1998;25:58-60.
11. Wang J,Hu J, JunM. Clinical observation of elemene emulsion associated with EP against small cell lung cancer. Chin J Clin Oncol 2000;27:312-313.
12. Liu JF. Clinical observation of elemene emulsion associated with MVP against middle and advanced lung cancer. Henan J Oncol 2000;13:434-435.
13. Li L, Li ZL, Shui LH. Effect of elemene emulsion associated with EP on 60 middle and advanced lung cancer patients. Shandong J Med 2001;41:44.
14. Zhou D. Randomized controlled trial of elemene plus VP comparing with VP against advanced non-small-cell lung cancer. Chin J Clin Oncol 2001;28:470-471.
15. Tang SS, Xue YB, Jiang GL. Elemene injection associated with EP against advanced non-small-cell lung cancer. Zhe Jiang Zhong Xi Yi Jie He Za Zhi 2002;12:215-216.
16. Chen NJ, Li H, Tan SS. Clinical observation of docetaxel associated with elemene emulsion against 68 advanced non-small-cell lung cancer patients. Chin J Clin Oncol 2005;32:896-897.
17. Guo HQ, Chen HL, Chu SL.The application of elemenum emulsion to multi-modality therapy for advanced non-small-cell lung cancer stage IIIB∼IV. J Chin Oncol 2007;16:471-473.
18. Chen YP, Zhuang WB, Liu YC. Clinical observation of elemene emulsion associated with DC against advanced non-small-cell lung cancer. Shandong J Med 2008;48:54-55.
19. Yan ZY, Wang LN. Clinical research of combined elemenum for injection with DP therapy in treating elderly patient with advanced non-small-cell lung cancer. J Hunan Coll Tradit ChinMed 2009;29:5-8.
20. Zhou L, Liu FQ, Zhang HM. Clinical observation of elemene injection combined paclitaxel chemotherapy on advanced stage non-small-cell lung cancer. Zhong Yao Yao Li Yu Lin Chuang 2009;25:54-55.
21. Chu DJ, Guo SG, Yao DE. To study elemene emulsion, gemcitabine, and cisplatin in the treatment of advanced non-small-cell lung cancer. Chin J Clin Med 2010;17:491-494.
22. Wang LH, Shen F. Elemene emulsion combined with NP chemotherapy in the treatment of advanced NSCLC patients. J Chin Oncol 2010;20:547-550.
23. Fan WJ, Zhang FJ, Shen JL. Effect of elemene against eighty-two cases suffering from middle and terminal liver cancer in artery thrombosis. Chin J Clin Med 2001;17:926-927.
24. Zhang ZP. Elemene emulsion combined with transcatheter arterial chemoembolization in the treatment for 22 cases with primary hepatocellular carcinoma. J Bengbu Med Coll 2001;26: 341.
25. Chen J,Wang F, Yang BH. Effect of elemene associated with intervention treatment against ninety-two cases suffering from middle and terminal live cancer. J Interv Radiol 2002;11:210-212.
26. Chen P, Huang P, Wu JB. Observation on the therapeutic effect of transcatheter arterial infusion chemotherapy combined with elemene emulsion for the treatment intermediate and late stage hepatic carcinoma. J Jiangxi Med Coll 2005;45:96-98.
27. Song J, Xu H, Tang JQ. Transcatheter hepatic arterial infusion chemotherapy combined with elemene emulsion for treatment of primary hepatic carcinoma. J Chin Pharmaceut 2007;16:23-24.
28. Lu LQ, Zhao TW. Observation on the therapeutic effect of transcatheter hepatic arterial chemoembolization infusion combined with elemene emulsion for metastatic liver carcinomas. Chin Arch Tradit Chin Med 2011;29:253-255.
29. Xu XM, Chen MC, Chen DL. Beta-elemene emulsion combined with transcatheter arterial chemoembolization in the treatment for 21 cases with advanced hepatocellular carcinoma. J ClinOncol 2011;17:363-365.
30. Yin ZM, Zhang Y, Xie Z. Elemene plus fluorouracil in the treatment of advanced gastric cancer. Chin J Clin Oncol 1996;23:810-813.
31. Ma XZ, Yao Y, Zhang H.Clinical study of LEF versus EFP program in the treatment of advanced gastric carcinoma. J Binzhou Med Coll 1999;22:242-244.
32. Wu CM, Li QQ, Zhao YL. Effect of elemene emulsion and 5-Fu therapy on advanced gastric carcinoma. JNorth SichuanMed Coll 2000;15:12-13.
33. Li X, Jia LQ, Chen ZQ. Clinical observation of elemene injection combined 5-Fu biochemical adjustment therapy on gastrointestinal adeno-carcinoma. J Chin-Japan FriendshipHosp 2004;18:6-9.
34. Huang XJ. Clinical observation of elemene emulsion associated with chemotherapy against gastric carcinoma. Chin J Tradit Chin Med 2005;3:40-41.
35. Wei QL, Shou JW. Elemenum emulsion combined with fluorouracil/ paclitaxel in the treatment of progressive gastric cancer. Zhengjiang J Clin Med 2008;10:588-589.
36. Qin ZQ, Lu LQ, Yuan GR. Elemene combined OLF program of treatment of advanced gastric cancer. Chin Arch Tradit ChinMed 2010;28:435-437.
37. Gu H, Li YK, Li MX. Efficacy of elemene injection combined chemotherapy in treatment of advanced gastric carcinoma.Mod J Integr Tradit ChinWest Med 2011;20:1438-1441.
38. Xu QL, Jie XY, Yin JL. Clinical observation of elemene emulsion combined with chemotherapy in the treatment of metastatic brain carcinomas. Zhong Liu Yan Jiu Yu Lin Chuang 2001;13:47- 48.
39. Xu YH, Dong B, Zhou HY. Observation on the therapeutic effect of transcatheter carotid infusion with elemene emulsion for metastatic brain carcinomas. Clin J Oncol 2004;31:1423-1424.
40. Zhao P, Yu CM, Hu YQ. Effect of elemene emulsion combined with chemotherapy against acute leukemia. Chin J Clin Oncol 1999;26:395-396.
41. Zhao SM, Zang H, Gu XC. Effect of elemene emulsion combined with chemotherapy against refractory acute nonlymphocytic leukemia. Chin J Clin Oncol 1999;26:530-531. (Pubitemid 29399714)
42. Zheng CP,Wang XL, ZhangWP. Effect of elemene emulsion combined with chemotherapy against refractory acute nonlymphocytic leukemia. Chin J Clin Oncol 1999;26:237-238.
43. Zheng CP, ZhangWP, Xu J. Effect of elemene emulsion combined with chemotherapy in treatment of refractory acute nonlymphocytic leukemia. J Clin Hematol 2001;14:211-212.
44. Chen J, Yang JM, Dong DY. Application of elemene emulsion in the elderly refractory leucemia. Zhong Guo Zhong Xi Yi Jie He Za Zhi 2004;24:935-936.
45. ZhuX,WuCY, Lin JH.Effect of elemene emulsioncombinedwith chemotherapy against osteogenic sarcoma. Guang Ming Zhong Yi 2011;26:2091-2092.
46. Hao LW, Lu SB, Yu LM. Effect of β-elemene derivative in combined with ADM on CEM/ADM cells growth. J Dalian Med Coll 2002;22:165-167.
47. Li X, Wang G, Zhao JH. Antiproliferative effect of β-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. CMLS CellMol Life Sci 2005;62:894-904. (Pubitemid 40655636)
48. Li QD, Wang GD, Zhang MC. β-elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis. Oncol Rep 2009;22:161-170.
49. Wu WZ, Liu KD, Tang XL. Preliminary study on the antitumour immuno-protectivemechanism of β-elemene. Chin JOncol 1999;21:405-407.
50. Jin M, Shi GX, Pu H. Comparative study on the active immunization antitumor effects strengthen way of elemenecombo tumor cell vaccine. J Dalian Med Coll 1999;21:168- 169.
51. Chen LB, Zhang J, Wang QH. Effects of β-elemene on immune function in mice with tomour. Zhong Liu Fang Zhi Za Zhi 1998;25:54.
52. Yao SJ, Liu BY, Hu F. Effects of β-elemene on NK and IL- 2 activities in mice with tomour. Chin Pharmaceut 2000;9: 19-20.
53. Chen G, Ding XF, Xiao JF. Effects of elemene piperazine on immune function in mice with tumor. J Shengyang Pharmaceut Coll 2007;24:238-241.
54. Xiao XP, Zhao YL, Liang XY, Wu LJ, Cui SQ, Guo AM, Wang W. Assessing the quality of RCTs on the effect of β-elemene, one ingredient of a Chinese herb, against malignant tumors. Contemp Clin Trials 2006;27:70-82. (Pubitemid 41758440)
55. Hewitt C, Hahn S, Torgerson DJ, Watson J, Bland JM. Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals. BMJ 2005;330:1057-1058. (Pubitemid 40646558)
56. He J, Du L, Liu GJ, Fu J, He X, Yu J. Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional Chinesemedicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews. Trials 2011;12:122.
57. Marwick C. Complementary, alternative therapies should face rigorous testing. IOM concludes. J Natl Cancer Inst 2005;97: 255-256. (Pubitemid 40310271)